1: Bacaër N, Pretorius C, Auvert B. An Age-Structured Model for the Potential
Impact of Generalized Access to Antiretrovirals on the South African HIV
Epidemic. Bull Math Biol. 2010 Mar 27. [Epub ahead of print] PubMed PMID:
20349152.

2: Walker A, Ford D, Gilks C, Munderi P, Ssali F, Reid A, Katabira E, Grosskurth
H, Mugyenyi P, Hakim J, Darbyshire J, Gibb D, Babiker A. Daily co-trimoxazole
prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on
combination antiretroviral therapy: an observational analysis of the DART cohort.
Lancet. 2010 Mar 26. [Epub ahead of print] PubMed PMID: 20347483.

3: Anglaret X, Eholie S. Co-trimoxazole, cART, and non-AIDS infectious diseases.
Lancet. 2010 Mar 26. [Epub ahead of print] PubMed PMID: 20347482.

4: Koplan JP, An WK, Lam RM. Hong Kong: a model of successful tobacco control in
China. Lancet. 2010 Mar 25. [Epub ahead of print] PubMed PMID: 20347129.

5: Yu X, Huang Y, Qu G, Xu J, Hui S. Safety and current status of blood
transfusion in China. Lancet. 2010 Mar 25. [Epub ahead of print] PubMed PMID:
20347128.

6: Xu D, Sun B, Wan X, Ke Y. Reformation of medical education in China. Lancet.
2010 Mar 25. [Epub ahead of print] PubMed PMID: 20347127.

7: Holmes MV, Desai M, Dosekun O, Holmes P, Lucas SB, Kulasegaram R. Is the
diagnosis at hand? Lancet. 2010 Mar 27;375(9720):1134. PubMed PMID: 20346819.

8: Yip WC, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for
health-care providers in China. Lancet. 2010 Mar 27;375(9720):1120-30. PubMed
PMID: 20346818.

9: Zhang J, Mauzerall DL, Zhu T, Liang S, Ezzati M, Remais JV. Environmental
health in China: progress towards clean air and safe water. Lancet. 2010 Mar
27;375(9720):1110-9. PubMed PMID: 20346817.

10: Sharma A, Dogra S, Mahajan R, Wanchu A, Singh S. An unusual cause of joint
swelling. Lancet. 2010 Mar 27;375(9720):1109. PubMed PMID: 20346816.

11: Rudan I, Chan KY, Zhang JS, Theodoratou E, Feng XL, Salomon JA, Lawn JE,
Cousens S, Black RE, Guo Y, Campbell H; WHO/UNICEF's Child Health Epidemiology
Reference Group (CHERG). Causes of deaths in children younger than 5 years in
China in 2008. Lancet. 2010 Mar 27;375(9720):1083-9. PubMed PMID: 20346815.

12: Greiner T. Who chooses the leaders of UN organisations? Lancet. 2010 Mar
27;375(9720):1082. PubMed PMID: 20346814.

13: Krieger N, Birn AE. Health reform battles in the USA. Lancet. 2010 Mar
27;375(9720):1081; author reply 1081-2. PubMed PMID: 20346812.

14: Lutumba P, Kande V, Boelaert M, Kayembe JM, Mampunza S. Research capacity
strengthening in the DRC. Lancet. 2010 Mar 27;375(9720):1080. PubMed PMID:
20346811.

15: Kang SM, Oh J, Hong N. High-dose versus low-dose losartan in patients with
heart failure. Lancet. 2010 Mar 27;375(9720):1079; author reply 1079-80. PubMed
PMID: 20346808.

16: Erol A. High-dose versus low-dose losartan in patients with heart failure.
Lancet. 2010 Mar 27;375(9720):1079; author reply 1079-80. PubMed PMID: 20346806.

17: Habersberger J, Eisenhardt S, Peter K. C-reactive protein measurement and
cardiovascular disease. Lancet. 2010 Mar 27;375(9720):1078. PubMed PMID:
20346805.

18: McMahon JW Sr. American Medical Association and patients' autonomy. Lancet.
2010 Mar 27;375(9720):1078; author reply 1079. PubMed PMID: 20346804.

19: Wald DS, Bestwick JP. C-reactive protein measurement and cardiovascular
disease. Lancet. 2010 Mar 27;375(9720):1077; author reply 1077-8. PubMed PMID:
20346802.

1: Jaeger BR, Labarrere CA. Genetic variants in Lp(a) lipoprotein and coronary
disease. N Engl J Med. 2010 Mar 25;362(12):1146-7; author reply 1147-8. PubMed
PMID: 20344827.

2: DesRoches CM, Rosenbaum SJ. Meaningful use of health information technology in
U.S. hospitals. N Engl J Med. 2010 Mar 25;362(12):1153-5. PubMed PMID: 20335600.

3: Arner E, Rydén M, Arner P. Tumor necrosis factor alpha and regulation of
adipose tissue. N Engl J Med. 2010 Mar 25;362(12):1151-3. PubMed PMID: 20335599.

4: Wallace DJ. Telomere diseases. N Engl J Med. 2010 Mar 25;362(12):1150. PubMed
PMID: 20335598.

5: Mackenzie A. Activated protein C for sepsis. N Engl J Med. 2010 Mar
25;362(12):1150-1; author reply 1151. PubMed PMID: 20335597.

6: Landzaat LH, Sinclair CT, Rosielle DA. Continuous-flow left ventricular assist
device. N Engl J Med. 2010 Mar 25;362(12):1149; author reply 1149. PubMed PMID:
20335596.

7: Littmann L. Early repolarization on electrocardiography. N Engl J Med. 2010
Mar 25;362(12):1148; author reply 1148. PubMed PMID: 20335595.

8: Kraft HG, Kronenberg F, Utermann G. Genetic variants in Lp(a) lipoprotein and
coronary disease. N Engl J Med. 2010 Mar 25;362(12):1146; author reply 1147-8.
PubMed PMID: 20335594.

9: Smeitink J. Metabolism, gliomas, and IDH1. N Engl J Med. 2010 Mar
25;362(12):1144-5. PubMed PMID: 20335593.

10: Diehl AM. Genetic susceptibility to hepatic steatosis. N Engl J Med. 2010 Mar
25;362(12):1142-3. PubMed PMID: 20335592.

11: Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with
cirrhosis. N Engl J Med. 2010 Mar 25;362(12):1140-2. PubMed PMID: 20335591.

12: Pless ML, Chen YB, Copen WA, Frosch MP. Case records of the Massachusetts
General Hospital. Case 9-2010. A 37-year-old woman with paresthesias and ataxia.
N Engl J Med. 2010 Mar 25;362(12):1129-38. PubMed PMID: 20335590.

13: Wills CP, River G. Images in clinical medicine. Herpes zoster. N Engl J Med.
2010 Mar 25;362(12):1128. PubMed PMID: 20335589.

14: Suh JH. Stereotactic radiosurgery for the management of brain metastases. N
Engl J Med. 2010 Mar 25;362(12):1119-27. PubMed PMID: 20335588.

15: Ross JS, Normand SL, Wang Y, Ko DT, Chen J, Drye EE, Keenan PS, Lichtman JH,
Bueno H, Schreiner GC, Krumholz HM. Hospital volume and 30-day mortality for
three common medical conditions. N Engl J Med. 2010 Mar 25;362(12):1110-8. PubMed
PMID: 20335587.

16: Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S,
Lapointe JY, Zelikovic I, Skorecki K. A loss-of-function mutation in NaPi-IIa and
renal Fanconi's syndrome. N Engl J Med. 2010 Mar 25;362(12):1102-9. PubMed PMID:
20335586.

17: Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu
D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National
Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men
and women in China. N Engl J Med. 2010 Mar 25;362(12):1090-101. PubMed PMID:
20335585.

18: Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura
J, Lifton RP, Shulman GI. Apolipoprotein C3 gene variants in nonalcoholic fatty
liver disease. N Engl J Med. 2010 Mar 25;362(12):1082-9. PubMed PMID: 20335584.

19: Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh
MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw
A, Bortey E, Forbes WP. Rifaximin treatment in hepatic encephalopathy. N Engl J
Med. 2010 Mar 25;362(12):1071-81. PubMed PMID: 20335583.

20: Schiff GD, Bates DW. Can electronic clinical documentation help prevent
diagnostic errors? N Engl J Med. 2010 Mar 25;362(12):1066-9. PubMed PMID:
20335582.

1: Torpy JM, Lynm C, Glass RM. JAMA patient page. Randomized controlled trials. JAMA. 2010 Mar 24;303(12):1216.

2: Glassock RJ. Referrals for chronic kidney disease: real problem or nuisance?JAMA. 2010 Mar 24;303(12):1201-3.

3: Dunn JR. Health behavior vs the stress of low socioeconomic status and health outcomes. JAMA. 2010 Mar 24;303(12):1199-200.

4: DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research: primum non nocere, revisited. JAMA. 2010 Mar 24;303(12):1196-8.

5: Nissen SE. Setting the RECORD Straight. JAMA. 2010 Mar 24;303(12):1194-5.

6: Insel TR. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution? JAMA. 2010 Mar 24;303(12):1192-3.

7: Krumholz HM. Informed consent to promote patient-centered care. JAMA. 2010 Mar 24;303(12):1190-1.

8: Gostin LO, Connors EE. Health care reform in transition: incremental insurance reform without an individual mandate. JAMA. 2010 Mar 24;303(12):1188-9.

9: Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D,Walter SD, Guyatt GH; STOPIT-2 Study Group, Flynn DN, Elamin MB, Murad MH, AbuElnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R,Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ,Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P,Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T.Stopping randomized trials early for benefit and estimation of treatment effects:systematic review and meta-regression analysis. JAMA. 2010 Mar 24;303(12):1180-7.Review.

10: Lee IM, Djoussé L, Sesso HD, Wang L, Buring JE. Physical activity and weight gain prevention. JAMA. 2010 Mar 24;303(12):1173-9.

11: Stenestrand U, Wijkman M, Fredrikson M, Nystrom FH. Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain. JAMA. 2010 Mar 24;303(12):1167-72.

12: Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010 Mar 24;303(12):1159-66.

13: Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, Klarenbach SW, Culleton BF, Krause R, Thorlacius L, Jain AK, Tonelli M; Alberta Kidney Disease Network. Nephrology visits and health care resource use before and after  reporting estimated glomerular filtration rate. JAMA. 2010 Mar 24;303(12):1151-8.

14: Charlier P, Huynh I. Assessment of atherosclerosis in Egyptian mummies. JAMA. 2010 Mar 24;303(12):1149-50; author reply 1150.

15: Wilber ST, Sullivan AF, Camargo CA Jr. Chronic pain and risk of falls in older adults. JAMA. 2010 Mar 24;303(12):1148; author reply 1148-9.

16: Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Chronic pain and risk of falls in older adults. JAMA. 2010 Mar 24;303(12):1147-8; author reply 1148-9.

17: Hsu CS, Kao JH. Use of statins and gallstone risk. JAMA. 2010 Mar
24;303(12):1146; author reply 1147.

18: Fujita T. Use of statins and gallstone risk. JAMA. 2010 Mar
24;303(12):1146-7; author reply 1147.

19: Mitka M. Aggressive glycemic control might not be best choice for all diabetic patients. JAMA. 2010 Mar 24;303(12):1137-8.

20: Kuehn BM. CDC advisory committee recommends nearly universal influenza vaccination. JAMA. 2010 Mar 24;303(12):1136.

1: Pullatt RC, Silverman DI, Heller GV. Are long-term outcomes of medium- to
high-risk patients undergoing vascular surgery affected by the ischemia
evaluation strategy? J Am Coll Cardiol. 2010 Mar 30;55(13):1397-8. PubMed PMID:
20338505.

2: Jabs A, Münzel T. Drug-eluting stent-induced vascular dysfunction common and
missing links. J Am Coll Cardiol. 2010 Mar 30;55(13):1399. PubMed PMID: 20338508.

3: Yasuda S, Shiroto T, Shimokawa H. Reply. J Am Coll Cardiol. 2010 Mar
30;55(13):1399-400. PubMed PMID: 20338507.

4: Monaco M, Stassano P, Di Tommaso L. Reply. J Am Coll Cardiol. 2010 Mar
30;55(13):1398. PubMed PMID: 20338506.

5: Rott D. Prophylactic coronary angiography improves outcome after major
vascular surgery. J Am Coll Cardiol. 2010 Mar 30;55(13):1396. PubMed PMID:
20338504.

6: Kaluski E. Prophylactic pre-operative coronary revascularization do we have
the data? J Am Coll Cardiol. 2010 Mar 30;55(13):1396-7. PubMed PMID: 20338503.

7: Pursnani AK, Levy NK, Benito M, Hong SN, Srichai MB, Yee H, Kronzon I.
Carney's Complex. J Am Coll Cardiol. 2010 Mar 30;55(13):1395. PubMed PMID:
20338502.

8: Kantor PF, Abraham JR, Dipchand AI, Benson LN, Redington AN. The Impact of
Changing Medical Therapy on Transplantation-Free Survival in Pediatric Dilated
Cardiomyopathy. J Am Coll Cardiol. 2010 Mar 30;55(13):1377-1384. PubMed PMID:
20338500.

9: Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, Schächinger V,
Seifried E, Zeiher AM, Dimmeler S. Red Blood Cell Contamination of the Final Cell
Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy.
J Am Coll Cardiol. 2010 Mar 30;55(13):1385-1394. PubMed PMID: 20338501.

10: El-Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, Leon
AR, Puskas JD. New-Onset Atrial Fibrillation Predicts Long-Term Mortality After
Coronary Artery Bypass Graft. J Am Coll Cardiol. 2010 Mar 30;55(13):1370-1376.
PubMed PMID: 20338499.

11: Gränsbo K, Melander O, Wallentin L, Lindbäck J, Stenestrand U, Carlsson J,
Nilsson J. Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial
Infarction Patients Receiving Statin Treatment. J Am Coll Cardiol. 2010 Mar
30;55(13):1362-1369. PubMed PMID: 20338498.

12: O'Gara PT. The COURAGE (Clinical Outcomes Utilizing Revascularization and
Aggressive Drug Evaluation) Trial Can We Deliver on Its Promise? J Am Coll
Cardiol. 2010 Mar 30;55(13):1359-61. PubMed PMID: 20338497.

13: Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Calfas KJ, Mancini GB, Spertus
JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM,
Gosselin G, Nawaz S, Gau GT, Blaustein AS, Bates ER, Shaw LJ, Berman DS, Chaitman
BR, Weintraub WS, Teo KK; COURAGE Trial Research Group. Intensive Multifactorial
Intervention for Stable Coronary Artery Disease Optimal Medical Therapy in the
COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug
Evaluation) Trial. J Am Coll Cardiol. 2010 Mar 30;55(13):1348-1358. PubMed PMID:
20338496.

14: Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Alcohol
Consumption and Mortality in Patients With Cardiovascular Disease A
Meta-Analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1339-1347. PubMed PMID:
20338495.

15: Klatsky AL. Alcohol and cardiovascular mortality common sense and scientific
truth. J Am Coll Cardiol. 2010 Mar 30;55(13):1336-8. PubMed PMID: 20338494.

16: Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol Consumption and
Cardiovascular Mortality Among U.S. Adults, 1987 to 2002. J Am Coll Cardiol. 2010
Mar 30;55(13):1328-1335. PubMed PMID: 20338493.

17: Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular
Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and
Meta-Analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1318-1327. PubMed PMID:
20338492.

18: Ford ES, Zhao G, Li C. Pre-Diabetes and the Risk for Cardiovascular Disease A
Systematic Review of the Evidence. J Am Coll Cardiol. 2010 Mar
30;55(13):1310-1317. PubMed PMID: 20338491.

19: Serebruany VL. Clopidogrel and heart failure survival missed opportunity or
wrong turn? J Am Coll Cardiol. 2010 Mar 30;55(13):1308-9. PubMed PMID: 20338490.

20: Bonde L, Sorensen R, Fosbøl EL, Abildstrøm SZ, Hansen PR, Kober L, Schramm
TK, Bretler DM, Weeke P, Olesen J, Torp-Pedersen C, Gislason GH. Increased
Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure
and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention
A Nationwide Study. J Am Coll Cardiol. 2010 Mar 30;55(13):1300-1307. PubMed PMID:
20338489.

1: Marwaha RK, Tandon N, Agarwal N, Puri S, Agarwal R, Singh S, Mani K. Impact of Two Regimens of Vitamin D Supplementation on Calcium Vitamin D PTH Axis of Schoolgirls of Delhi. Indian Pediatr. 2010 Jan 15. pii: S097475590900056-1. [Epub ahead of print]

2: Uppal P, Paul P, Sreenivas V. School Absenteeism Among Children and its Correlates A Predictive Model for Identifying Absentees. Indian Pediatr. 2010 Jan 15. pii: S097475590900142-1. [Epub ahead of print]

3: Nair PS, Sobhakumar S, Kailas L. Diagnostic Re-evaluation of Children with Congenital Hypothyroidism. Indian Pediatr. 2010 Jan 15. pii: S097475590900172-1.  [Epub ahead of print]

4: Chaudhari S, Bhalerao M, Chitale A, Patil B, Pandit A, Hoge M. Transient Tone  Abnormalities in High Risk Infants and Cognitive Outcome at Five Years. Indian Pediatr. 2010 Jan 15. pii: S097475590900196-1. [Epub ahead of print]

5: Islam MN, Chowdhury M, Siddika M, Qurishi SB, Bhuiyan MK, Hoque MM, Akhter S.  Effect of Oral Zinc Supplementation on the Growth of Preterm Infants. Indian Pediatr. 2010 Jan 15. pii: S097475590900473-1.

6: Murki S, Jonnala S, Mohammed F, Reddy A. Restriction of Cephalosporins and Control of Extended Spectrum Beta Lactamase Producing Gram Negative Bacteria in a Neonatal Intensive Care Unit. Indian Pediatr. 2010 Jan 15. pii: S097475590900281-2.

7: Rai R, Singh DK. Intravenous Adrenaline for Shock in Neonates. Indian Pediatr. 2010 Jan 15. pii: S097475590900332-2.

8: Khadilkar VV, Khadilkar AV, Chiplonkar SA. Growth Performance of Affluent Indian Preschool Children A Comparison with the New WHO Growth Standard. Indian Pediatr. 2010 Jan 15. pii: S097475590900451-1.

9: Sharma A, Grover N, Kaushik S, Bhardwaj R, Sankhyan N. Prevalence of
Hypertension Among School Children in Shimla. Indian Pediatr. 2010 Jan 15. pii: S097475590900381-1.

10: Lin CG, Schaider LA, Brabander DJ, Woolf AD. Pediatric Lead Exposure From Imported Indian Spices and Cultural Powders. Pediatrics. 2010 Mar 15.

11: Khubchandani R. Kawasaki disease--call for a national registry for India. Indian Pediatr. 2010 Feb 7;47(2):200.

12: Paul Y. Cross system practice and prescription. Indian Pediatr. 2010 Feb 7;47(2):199; discussion 199-200.

13: Zaki SA, Shanbag P. Pseudoaneurysm following modified Blalock Taussig shunt.Indian Pediatr. 2010 Feb 7;47(2):198-9.

14: Sibal A, Kaur S. Creating awareness about pediatric cadaver organ donation in India. Indian Pediatr. 2010 Feb 7;47(2):197.

15: Sanghvi JP. Recurrent breath holding spells with infantile colic. Indian Pediatr. 2010 Feb 7;47(2):196.

16: Bains HS, Dhooria GS. Malignant otitis externa. Indian Pediatr. 2010 Feb 7;47(2):195-6.

17: Kumar KV, Verma A, Modi KD, Rayudu BR. Precocious puberty and pineal cyst—an uncommon association. Indian Pediatr. 2010 Feb 7;47(2):193-4.

18: Bhatia V, Das MK, Kumar P, Arora NK. Infantile hookworm disease. Indian Pediatr. 2010 Feb 7;47(2):190-2.

19: Mondal R, Nandi M, Dhibar T. Protein C and protein S deficiency presenting as deep venous thrombosis. Indian Pediatr. 2010 Feb 7;47(2):188-9.

20: Zaki SA, Dadge D, Shanbag P. Diaphragmatic hernia presenting as
gastrointestinal bleeding. Indian Pediatr. 2010 Feb 7;47(2):185-7.

1: Spengos K, Walter MC, Dekomien G, Papadopoulos K, Lochmüller H, Manta P. C283Y mutation in the gamma-sarcoglycan gene in Greek Gypsies with severe limb girdle muscular dystrophy. Eur J Neurol. 2010 Mar 22.

2: Johnsen EL, Sunde N, Mogensen PH, Ostergaard K. MRI verified STN stimulation site - gait improvement and clinical outcome. Eur J Neurol. 2010 Mar 22.

3: Handel AE, Handunnetthi L, Giovannoni G, Ebers GC, Ramagopalan SV. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol. 2010 Mar 22.

4: Winter Y, Balzer-Geldsetzer M, Spottke A, Reese JP, Baum E, Klotsche J, Rieke J, Simonow A, Eggert K, Oertel WH, Dodel R. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur J Neurol. 2010 Mar 22.

5: Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010 Mar 8.

6: Hendricks HT, Heeren AH, Vos PE. Dysautonomia after severe traumatic brain injury. Eur J Neurol. 2010 Mar 9.

7: Hoshi T, Yamagami H, Furukado S, Miwa K, Tanaka M, Sakaguchi M, Sakoda S, Kitagawa K. Serum inflammatory proteins and frontal lobe dysfunction in patients  with cardiovascular risk factors. Eur J Neurol. 2010 Mar 9.

8: Annweiler C, Le Gall D, Fantino B, Beauchet O. Fish consumption and dementia:  keep the vitamin D in memory. Eur J Neurol. 2010 Mar 9.

9: Manobianca G, Zoccolella S, Petruzzellis A, Miccoli A, Logroscino G. The incidence of major stroke subtypes in Southern Italy: a population-based study.Eur J Neurol. 2010 Mar 11

10: Denier C, Guedj T, Dinanian S, Adams D. Brugada syndrome revealed by vertigo caused by cerebellar infarction. Eur J Neurol. 2010 Mar 9.

11: Nishio Y, Hirayama K, Takeda A, Hosokai Y, Ishioka T, Suzuki K, Itoyama Y,Takahashi S, Mori E. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol. 2010 Mar 9.

12: Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T. EFNS guidelines on the molecular  diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. Eur J  Neurol. 2010 Mar 9.

13: Sabolek M, Runge U. Lamotrigine induced dyskinesia in Parkinson's disease. Eur J Neurol. 2010 Mar 17.

14: Reichmann H, Jost WH. Efficacy and tolerability of rasagiline in daily clinical use - a post-marketing observational study in patients with Parkinson's  disease. Eur J Neurol. 2010 Mar 17.

15: Congedo M, Causarano RI, Alberti F, Bonito V, Borghi L, Colombi L, Defanti CA, Marcello N, Porteri C, Pucci E, Tarquini D, Tettamanti M, Tiezzi A,Tiraboschi P, Gasparini M; For the Bioethics and Palliative Care in Neurology Study Group of the Italian Society of Neurology. Ethical issues in end of life treatments for patients with dementia. Eur J Neurol. 2010 Mar 17.

16: Jellinger KA. Bacterial Infections of the Central Nervous System. Eur J Neurol. 2010 Mar 17. [Epub ahead of print]

17: Jellinger KA. Meningiomas. A Comprehensive Text. Eur J Neurol. 2010 Mar 17.

18: Costello S, Bordelon Y, Bronstein J, Ritz B. Familial associations of Alzheimer disease and essential tremor with Parkinson disease. Eur J Neurol. 2010 Mar 17.

19: Nguyen TH, Truong AL, Ngo MB, Bui CT, Dinh QV, Doan TC, Nguyen LT, Phan TC,Phan MV, Nguyen TV, Le TV. Patients with Thrombolysed Stroke in Vietnam have an Excellent Outcome: Results from the Vietnam Thrombolysis Registry. Eur J Neurol. 2010 Mar 17.

20: Lehmann HC, Hoffmann FR, Meyer Zu Hörste G, Hartung HP, Kieseier BC. Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy. Eur J Neurol. 2010 Mar 17.

1. Eur Heart J. 2010 Mar;31(6):629-30.
The fingertip test which could save millions.

2. Eur Heart J. 2010 Mar;31(6):630-2.
Trials and tribulations.

3. Eur Heart J. 2010 Mar 23. [Epub ahead of print]
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jaïs P, Hocini M,Haïssaguerre M. Hôpital Cardiologique Haut-Lévêque, Avenue de Magellan, 33 604, Bordeaux-Pessac
cedex, Université Victor Segalen, France. Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter ablation is increasingly being used to treat patients with AF, and recent studies have reported success rates >80% for paroxysmal AF and >70% for
persistent AF. The purpose of this work is to review the evidence supporting catheter ablation and compare it with pharmacological treatment in the management of AF.

4. Eur Heart J. 2010 Mar 21. Exercise echocardiography in aortic stenosis: one more piece in the puzzle.Zamorano JL, Goncalves A.
University Clinic San Carlos, Madrid, Spain.

5. Eur Heart J. 2010 Mar 21.
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Maréchaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A, Bergeron
S, Arsenault M, Le Tourneau T, Ennezat PV, Pibarot P. Centre
Hospitalier Régional et Universitaire de Lille, EA2693, Lille F-59019,
France.

Aims Abnormal exercise test defined as the occurrence of exercise limiting symptoms, fall in blood pressure below baseline, or complex ventricular arrhythmias is useful to predict clinical events in asymptomatic patients with aortic stenosis (AS). The purpose of this study was to determine whether exercise-stress echocardiography (ESE) adds any incremental prognostic value to resting echocardiography in patients with AS having a normal exercise response. Methods and results One hundred and eighty-six asymptomatic patients with at least moderate AS and preserved LV ejection fraction (>/=50%) were assessed by Doppler-echocardiography at rest and during a maximum ramp semi-supine bicycle exercise test. Fifty-one (27%) patients had an abnormal exercise test and were excluded from the present analysis. Among the 135 patients with normal exercise test, 67 had an event (aortic valve replacement motivated by symptoms or cardiovascular death) at a mean follow-up of 20 +/- 14 months. The variables independently associated with events were: age >/=65 years [hazard ratio (HR) = 1.96; 95% confidence interval (CI): 1.15-3.47; P = 0.01], diabetes, (HR = 3.20;
95% CI: 1.33-6.87; P = 0.01), LV hypertrophy (HR = 1.96; 95% CI: 1.17-3.27; P = 0.01), resting mean gradient >35 mmHg (HR = 3.60; 95% CI: 2.11-6.37; P < 0.0001), and exercise-induced increase in mean gradient >20 mmHg (HR = 3.83; 95% CI: 2.16-6.67; P < 0.0001). Conclusion The exercise-induced increase in transvalvular gradient may be helpful to improve risk stratification in asymptomatic AS patients with normal exercise response. These results thus suggest that ESE may provide additional prognostic information over that obtained from standard
exercise testing and resting echocardiography.




6. Eur Heart J. 2010 Mar 19.

Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and  decreases leaflet inflammation in an experimental rabbit model. Speidl WS, Cimmino G, Ibanez B, Elmariah S, Hutter R, Garcia MJ, Fuster V,Goldman ME, Badimon JJ. Atherothrombosis Research Unit, Mount Sinai School of Medicine New York, NY, USA.

Aims Aortic stenosis (AS) is associated with significant morbidity and mortality. Recombinant apolipoprotein A-I Milano (rApoA-I(M)) induces atherosclerotic plaque regression. The aims of this study were to determine the effects of rApoA-I(M) on experimental aortic valve degeneration and its mechanisms of action. Methods and  results New Zealand White rabbits (n = 20) were fed an atherogenic diet for 9
months and then randomized to either placebo or rApoA-I(M). Echocardiography was  used to assess the effect of the treatments on AS. Porcine aortic valve myofibroblasts (PAVMF) treated with oxidized low-density lipoprotein served to define the effects of rApoA-I(M) on the expression of monocyte chemoattractant protein-1 (MCP-1), nuclear factor (NF)-kappaB, and alkaline phosphatase (AP). Recombinant apolipoprotein A-I Milano increased aortic valve area (AVA) by 32%
(0.25 +/- 0.05 to 0.34 +/- 0.07 cm(2), P < 0.01); whereas AVA remained unchanged  in the placebo group (0.24 +/- 0.05 to 0.26 +/- 0.04 cm(2), P = 0.58). Histopathological examination of aortic valves in the rApoA-I(M) animals showed significantly less leaflet thickening, inflammation, and calcification vs. the placebo group. In vitro, rApoA-I(M) significantly inhibited MCP-1, AP, and NF-kappaB and decreased intracellular cholesterol content in PAVMF. Conclusion Recombinant apolipoprotein A-I Milano treatment reverses AS in this experimental
rabbit model. The beneficial effects seem to be mediated by enhanced cholesterol  removal and by reduced inflammation and calcification.

7. Eur Heart J. 2010 Mar 19. [Epub ahead of print]

Gender differences in heart failure: paving the way towards personalized
medicine?

Schirmer SH, Hohl M, Böhm M.

Klinik für Innere Medizin III (Kardiologie, Angiologie und Internistische
Intensivmedizin), Universitätsklinikum des Saarlandes, D-66424 Homburg/Saar,
Germany.

8. Eur Heart J. 2010 Mar 19. [Epub ahead of print]

Persistence of muscle sympathetic nerve activity during vasovagal syncope.

Vaddadi G, Esler MD, Dawood T, Lambert E.

Human Neurotransmitter Laboratory, BakerIDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia.

Aims To determine whether sympathetic nerve firing to skeletal muscle vasculature is withdrawn during vasovagal syncope (VVS) precipitated by passive graded head-up tilt (HUT) table testing. Methods and results We performed passive graded HUT table testing in 18 patients with a history of recurrent postural VVS whom we evaluated during the syncopal event. All patients developed typical VVS during testing. Blood pressure was measured continuously via intra-brachial arterial line. Muscle sympathetic nerve activity (MSNA) was measured using an electrode in the peroneal nerve. Passive graded HUT was then applied. No pharmacological agents were used to provoke syncope. The recording site was maintained through the syncopal event in 10 of 18 patients and we were able to demonstrate persistence of MSNA during syncope in 9. The predominant haemodynamic pattern of  syncope in this cohort was mixed-hypotension and bradycardia, with heart rate not falling <40 b.p.m. (n = 10). Conclusion Our data challenge the established view that the final trigger for human orthostatic vasovagal reactions is sympathetic nervous system inhibition. Efferent sympathetic nerve traffic to the skeletal muscle vasculature was nearly always maintained through the faint. This finding supports an alternative viewpoint, that vasodilator mechanisms underlie the blood pressure fall in VVS.

9. Eur Heart J. 2010 Mar 18. [Epub ahead of print]

Stroke risk in AF: do AF patterns matter?

Lubitz SA, Rosen AB, Ellinor PT, Benjamin EJ.

Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA,
USA.

10. Eur Heart J. 2010 Mar 18. [Epub ahead of print]

Growth differentiation factor-15 and cardiovascular dysfunction and disease:
malefactor or innocent bystander?

Taddei S, Virdis A.

Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa,
Italy.

11. Eur Heart J. 2010 Mar 18. [Epub ahead of print]

Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic  heart failure.

Van Craenenbroeck EM, Beckers PJ, Possemiers NM, Wuyts K, Frederix G, Hoymans VY,
Wuyts F, Paelinck BP, Vrints CJ, Conraads VM.

Department of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, 2650
Edegem, Belgium.

Aims Recruitment of endothelial progenitor cells (EPCs) and enhanced activity of  circulating angiogenic cells (CACs) might explain the benefits of exercise training in reversing endothelial dysfunction in chronic heart failure (CHF) patients. We studied baseline EPC numbers and CAC function and the effect of a single exercise bout. Methods and results Forty-one CHF patients (mild, n = 22; severe, n = 19) and 13 healthy subjects were included. Migratory activity of CACs was evaluated in vitro and circulating CD34+ and CD34+/KDR+ (EPC) cells were quantified by flow cytometry before and after cardiopulmonary exercise testing (CPET). Circulating stromal cell-derived factor-1alpha (SDF-1alpha) and vascular  endothelial growth factor (VEGF) concentrations were measured. Both CAC migration as well as CD34+ cell numbers were significantly reduced in CHF, whereas
CD34+/KDR+ cells were not different from controls. Endothelial dysfunction was related to impaired CAC migration (r = 0.318, P = 0.023). Cardiopulmonary exercise testing improved CAC migration in severe (+52%, P < 0.005) and mild CHF  (+31%, P < 0.005), restoring it to levels similar to controls. Following CPET, SDF-1alpha increased in healthy controls and mild CHF (P < 0.005). Vascular endothelial growth factor, CD34+, and CD34+/KDR+ cell numbers remained unchanged.
Conclusion The present findings reveal a potent stimulus of acute exercise to reverse CAC dysfunction in CHF patients with endothelial dysfunction.

12. Eur Heart J. 2010 Mar 18. [Epub ahead of print]

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Wordsworth S, Leal J, Blair E, Legood R, Thomson K, Seller A, Taylor J, Watkins
H.

Health Economics Research Centre, University of Oxford, Old Road Campus, Oxford
OX3 7LF, UK.

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac  disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing cascade screening by genetic, as opposed to clinical methods. The incremental cost per life year saved was euro14 397 for the cascade genetic compared with the cascade clinical approach. Genetic diagnostic strategies are more likely to be cost-effective than clinical tests alone. The costs for cascade molecular genetic testing were slightly higher than clinical testing in the short run, but this was largely because the genetic approach is more effective and identifies more individuals at risk. Conclusion The use of molecular genetic information in the diagnosis and management of HCM is a cost-effective approach to the primary prevention of SCD
in these patients.


13. Eur Heart J. 2010 Mar 18. [Epub ahead of print]

Percutaneous mitral valve repair with the MitraClip system: acute results from a  real world setting.

Tamburino C, Ussia GP, Maisano F, Capodanno D, Canna GL, Scandura S, Colombo A,
Giacomini A, Michev I, Mangiafico S, Cammalleri V, Barbanti M, Alfieri O.
Cardiology Department, Ferrarotto Hospital, University of Catania, Via Citelli 6,
95124 Catania, Italy.

Aims This study sought to evaluate the feasibility and early outcomes of a percutaneous edge-to-edge repair approach for mitral valve regurgitation with the MitraClip((R)) system (Evalve, Inc., Menlo Park, CA, USA). Methods and results Patients were selected for the procedure based on the consensus of a multidisciplinary team. The primary efficacy endpoint was acute device success defined as clip placement with reduction of mitral regurgitation to </=2+. The primary acute safety endpoint was 30-day freedom from major adverse events, defined as the composite of death, myocardial infarction, non-elective cardiac
surgery for adverse events, renal failure, transfusion of >2 units of blood, ventilation for >48 h, deep wound infection, septicaemia, and new onset of atrial fibrillation. Thirty-one patients (median age 71, male 81%) were treated between  August 2008 and July 2009. Eighteen patients (58%) presented with functional disease and 13 patients (42%) presented with organic degenerative disease. A clip was successfully implanted in 19 patients (61%) and two clips in 12 patients (39%). The median device implantation time was 80 min. At 30 days, there was an
intra-procedural cardiac tamponade and a non-cardiac death, resulting in a primary safety endpoint of 93.6% [95% confidence interval (CI) 77.2-98.9]. Acute  device success was observed in 96.8% of patients (95% CI 81.5-99.8). Compared with baseline, left ventricular diameters, diastolic left ventricular volume, diastolic annular septal-lateral dimension, and mitral valve area significantly diminished at 30 days. Conclusion Our initial results with the MitraClip device in a very small number of patients indicate that percutaneous edge-to-edge mitral
valve repair is feasible and may be accomplished with favourable short-term safety and efficacy results.

14. Eur Heart J. 2010 Mar 16. [Epub ahead of print]

Mannose-binding lectin: an ancient molecule with new implications in myocardial infarction.
Grundmann S, Bode C, Moser M.
Department of Internal Medicine III, University Hospital Freiburg, Germany.

15. Eur Heart J. 2010 Mar 16. [Epub ahead of print]

Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
Fröhlich G, Steffel J, Hürlimann D, Enseleit F, Lüscher TF, Ruschitzka F, Abraham WT, Holzmeister J.

Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistrasse 100,  Zurich CH-8091, Switzerland.

Aims Chronic right ventricular (RV) pacing may impose ventricular dyssynchrony leading to LV remodelling and is associated with increased morbidity and mortality. Upgrading patients with chronic RV pacing to cardiac resynchronization therapy (CRT) may be considered to restore synchronicity and prevent these deleterious effects. Methods and results A total of 172 patients from two tertiary centres were analysed over a mean follow-up of 21.7 and 23.5 months after primary CRT implantation (n = 102) and CRT upgrade (n = 70), respectively.
In the latter group, mean duration of RV pacing before CRT upgrade was 80.3 months, and ventricular stimulation was >95%. A significant improvement in left ventricular (LV) ejection fraction (10 and 11% absolute increase in primary CRT vs. upgrades, respectively), LV end-diastolic diameter index (-0.15 cm/m(2) vs. -0.2 cm/m(2)), and LV end-systolic diameter (-6.0 vs. -7.0 mm) was observed in both groups, which did not differ between primary CRT recipients and CRT upgrades. Response to CRT upgrade was independent of the underlying rhythm, QRS
duration, duration of prior RV pacing, or LV function and size at baseline. Of note, even seven of nine patients with RV pacing >12 years responded favourably to CRT. Conclusion The current study demonstrates that CRT reverses LV remodelling in heart failure patients with chronic RV pacing in a similar way as  in primary CRT recipients, even after very long periods of RV pacing. Our data, therefore, may have important implications for the treatment of pacemaker-dependent patients with heart failure, and support the use of CRT in this setting.

16. Eur Heart J. 2010 Mar 16. [Epub ahead of print]

Genetics of ACS and recurrent MI/cardiac death: are we getting to the heart of the (atherosclerotic) matter?
Monraats PS, Jukema JW.
Department of Cardiology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands.

17. Eur Heart J. 2010 Mar 16.
The diagnostic accuracy of 256-row computed tomographic angiography compared with invasive coronary angiography in patients with suspected coronary artery disease.
Chao SP, Law WY, Kuo CJ, Hung HF, Cheng JJ, Lo HM, Shyu KG.
Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, No. 95, Wenchang Road, Taipei 111, Taiwan.

Aims To assess the diagnostic accuracy of 256-row computed tomographic
angiography (CTA) in patients with suspected coronary artery disease (CAD). Non-invasive imaging of the coronary artery by CTA has increasingly been used in  recent years. The accuracy of 256-row CTA has not yet been studied. We sought to  assess the accuracy of 256-row CTA compared with invasive coronary angiography (ICA) in the diagnosis and assessment of CAD. Methods and results We prospectively evaluated 104 consecutive individuals who accepted CTA and then underwent ICA. The presence of stenosis >/=50% was considered obstructive. The
diagnostic accuracy of CTA for detecting obstructive stenosis was compared with that of ICA. The area under the receiver-operating-characteristic curve (AUC) was used to evaluate the diagnostic accuracy of CTA relative to ICA. A total of 86 patients had obstructive CAD. The patient-based analysis of CTA for detecting stenosis >/=50% according to ICA revealed an AUC of 0.744 [95% confidence interval (CI), 0.572-0.916], with a sensitivity of 98.8%, a specificity of 50%, a positive predictive value (PPV) of 92.4%, and a negative predictive value (NPV) of 87.5%. The segment-based analysis revealed an AUC of 0.915 (95% CI,
0.847-0.982), with a sensitivity of 93.5%, a specificity of 95%, a PPV of 77.6%,  and an NPV of 98.7%. The vessel-based analysis revealed an AUC of 0.887 (95% CI,  0.808-0.966), with a sensitivity of 94.3%, a specificity of 87.3%, a PPV of 82.7%, and an NPV of 95.9%. Conclusion 256-Row CTA is a highly sensitive test of  CAD and has a high predictive value. 256-Row CTA may be a potential alternative
to detect coronary artery stenosis and rule out CAD in suspected patients.

18. Eur Heart J. 2010 Mar 16.
Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised.
Richter S, Sarkozy A, Paparella G, Henkens S, Boussy T, Chierchia GB, Brugada R,  Brugada J, Brugada P.

Heart Rhythm Management Centre, Cardiovascular Centre, Free University of Brussels (UZ Brussel) VUB, Laarbeeklaan 101, Brussels 1090, Belgium.

Aims According to the diagnostic consensus criteria, the electrocardiographic (ECG) diagnosis of Brugada syndrome requires coved-type >/=2 mm ST-segment elevation in >1 right precordial lead (RPL) V1-V3 in the presence or absence of a sodium-channel blocker. However, this consensus has not been evaluated. We aimed  to assess the distribution of coved-type ST-segment elevation on RPLs in a large  patient cohort to reevaluate the appropriateness of the diagnostic consensus criteria. Methods and results We included 186 individuals with spontaneous and/or drug-induced ECGs of coved-type >/=2 mm ST-segment elevation in at least one RPL. A total of 376 ECGs were analysed for the number, distribution and maximal J-point elevation of diagnostic RPLs. Among all ECGs, 27 (7%) showed a coved-type
pattern in 3 RPLs, 205 (55%) in 2 RPLs, and 144 (38%) in only 1 RPL. Leads V1 and V2 were diagnostic in 99% of all ECGs with two diagnostic RPLs. Lead V3 alone was not diagnostic in any ECG. Maximal J-point elevation was significantly higher in  lead V2 than V1. Sixty case subjects (32%) had only ECGs with one RPL displaying  a coved-type ST-segment elevation. There was no significant difference in clinical presentation and outcome compared with the 126 Brugada patients with
ECGs displaying >1 diagnostic RPL. Major arrhythmic events occurred with the same rate (8%) in both groups during a follow-up >5 years. Conclusion Lead V3 does not yield diagnostic information in Brugada syndrome. Individuals with ECGs displaying only one diagnostic RPL have a similar clinical profile and arrhythmic risk as Brugada patients with ECGs displaying >1 diagnostic RPL. Revision of the  consensus criteria should be considered.

19. Eur Heart J. 2010 Mar 16.
Transapical aortic valve implantation in 100 consecutive patients: comparison to  propensity-matched conventional aortic valve replacement.
Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Rückert Y, Ender J, Linke A, Scholz M, Falk V, Mohr FW.

Department of Cardiac Surgery, Heartcenter, University Leipzig, Herzzentrum, Klinik für Herzchirurgie, Strümpellstrasse 39, Leipzig 04289, Germany.

Aims To evaluate the outcome of transapical aortic valve implantation (TA-AVI) in comparison to conventional surgery. Methods and results One hundred consecutive high-risk patients with symptomatic aortic valve stenosis received TA-AVI using the Edwards SAPIEN pericardial xenograft between February 2006 and January 2008.  Patient age was 82.7 +/- 5 years, 77 were females, logistic EuroSCORE predicted risk of mortality was 29.4 +/- 13% and Society Thoracic Surgeons score risk for
mortality was 15.2 +/- 8.3%. Propensity score analysis was used to identify a control group of patients that underwent conventional aortic valve replacement (C-AVR). Transapical aortic valve implantation was performed successfully in 97 patients, whereas three patients required early conversion. There were no new onset neurological events in the TA-AVI group and early extubation was performed  in 82 patients. Echocardiography revealed good valve function with low transvalvular gradients in all patients. Thirty-day survival was 90 +/- 3 vs. 85
+/- 4% for TA-AVI vs. C-AVR, and 1-year survival was 73 +/- 4 vs. 69 +/- 5% (P =  0.55). Conclusion Transapical aortic valve implantation is a safe, minimally invasive, and off-pump technique to treat high-risk patients with aortic stenosis. Results of the initial 100 patients are good and compare favourably to  conventional surgery.

20. Eur Heart J. 2010 Mar;31(6):632-3.

Retired, but still motoring on: a lead investigator in the MADIT-CRT trial dreams of building a hospital in Paraguay.

1: Olansky L, Kennedy L. Finger-Stick Glucose Monitoring: Issues of accuracy and  specificity. Diabetes Care. 2010 Apr;33(4):948-9.

2: The TRIAD Study Group. Health Systems, Patients Factors, and Quality of Care for Diabetes: A synthesis of findings from the TRIAD Study. Diabetes Care. 2010 Apr;33(4):940-947.

3: Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL. Postoperative Mortality in Cancer Patients With Preexisting Diabetes: Systematic review and meta-analysis. Diabetes Care. 2010 Apr;33(4):931-9.

4: Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, Bower P. Identifying  Psychosocial Interventions That Improve Both Physical and Mental Health in Patients With Diabetes: A systematic review and meta-analysis. Diabetes Care. 2010 Apr;33(4):926-30.

5: Frias JP, Lim CG, Ellison JM, Montandon CM. Review of Adverse Events
Associated With False Glucose Readings Measured by GDH-PQQ-Based Glucose Test Strips in the Presence of Interfering Sugars. Diabetes Care. 2010 Apr;33(4):728-9.

6: Yamamoto M, Yamaguchi T, Yamauchi M, Sugimoto T. Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients with Type 2 Diabetes: Response to Yamagishi. Diabetes Care. 2010 Apr;33(4):e59.

7: Yamagishi S. Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes: Response to Yamamoto et al. Diabetes Care. 2010 Apr;33(4):e58.

8: Davidson MB. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr;33(4):e57.

9: Eraso LH, Reilly MP. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes: response to stefan et Al. Diabetes Care. 2010 Apr;33(4):e56.

10: Stefan N, Weikert C, Ix JH, Fritsche A, Häring HU. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes: response to eraso et Al. Diabetes Care. 2010 Apr;33(4):e55.

11: Bloomgarden ZT. Cardiovascular disease in diabetes. Diabetes Care. 2010 Apr;33(4):e49-54.

12: Rosenstock J, Klaff LJ, Schwartz S, Northrup J, Holcombe JH, Wilhelm K, Trautmann M. Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Prediabetes. Diabetes Care.  2010 Mar 23.

13: Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, Heptulla RA. The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes. Diabetes Care. 2010 Mar 23.

14: Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM,
Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski  AS. High-Normal Serum Uric Acid Increases Risk of Early Declining Renal Function  In Type 1 Diabetes: Results of 6-year Follow-up. Diabetes Care. 2010 Mar 23.


15: Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes. Diabetes Care. 2010 Mar 23.

16: Liu B, Jorm L, Banks E. PARITY, BREASTFEEDING AND THE SUBSEQUENT RISK OF MATERNAL TYPE 2 DIABETES. Diabetes Care. 2010 Mar 23.

17: The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes. Diabetes Care. 2010 Mar 23.

18: Redmon JB, Bertoni AG, Connelly S, Fenney PA, Glasser S, Glick H, Greenway F, Hesson LA, Lawlor MS, Montez M, Montgomery B. Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes. Diabetes Care. 2010 Mar 23.

19: Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Randomized Clinical Trial of Quick Release-Bromocriptine among Patients with Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 2010 Mar 23.

20: Buse JB, Sesti G, Schmidt WE, Montanya E, Chang CT, Xu Y, Blonde L,
Rosenstock J; for the Liraglutide Effect and Action in Diabetes (LEAD)-6 Study Group. Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents. Diabetes Care. 2010 Mar 23.

1. Circulation. 2010 Mar 30; 121(12):1459-60.

Wide-field scanning laser ophthalmoscope imaging and angiography of central retinal vein occlusion.

Kernt M, Ulbig MW.

Department of Ophthalmology, Ludwig Maximilian University, Mathildenstrasse 8,
80336 Muenchen, Germany. This e-mail address is being protected from spambots. You need JavaScript enabled to view it .


2. Circulation. 2010 Mar 30;121(12):1455-8.

Medication adherence in cardiovascular disease.

Baroletti S, Dell'orfano H.

Department of Pharmacy, MetroWest Medical Center, 115 Lincoln St, Framingham, MA

3. Circulation. 2010 Mar 30;121(12):1447-54.

Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.

Eagle KA, Ginsburg GS, Musunuru K, Aird WC, Balaban RS, Bennett SK, Blumenthal RS, Coughlin SR, Davidson KW, Frohlich ED, Greenland P, Jarvik GP, Libby P, Pepine CJ, Ruskin JN, Stillman AE, Van Eyk JE, Tolunay HE, McDonald CL, Smith SC Jr.

4. Circulation. 2010 Mar 30;121(12):e252.

Letter by winter et Al regarding article, "children and adults with congenital heart disease lost to follow-up: who and when?".

Winter MM, Mulder BJ, van der Velde ET.

5. Circulation. 2010 Mar 30;121(12):e250-1.

Dynamic right ventricular outflow tract obstruction due to a swinging echolucent cyst on interventricular septum in a 4-year-old girl.

Sugino N, Mitani Y, Ohashi H, Hayakawa H, Hosoki K, Takabayashi S, Shimpo H, Komada Y.

Department of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie Prefecture, 514-8507, Japan.

6. Circulation. 2010 Mar 29.

Toward Definitive Trials and Improved Outcomes of Cardiac Arrest.

Weisfeldt ML, Sugarman J, Bandeen-Roche K.

Department of Medicine, Berman Institute of Bioethics, and the Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md.

7. Circulation. 2010 Mar 29. [Epub ahead of print]

Gravitational Influences and Shifting Propensity for Sleep Apnea. Another Source of Heterogeneity or a New Intervention Target?

Redline S, Lewis EF.
Case Western Reserve University, Cleveland, Ohio, and Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

8. Circulation. 2010 Mar 29. [Epub ahead of print]

DEFI 2005. A Randomized Controlled Trial of the Effect of Automated External Defibrillator Cardiopulmonary Resuscitation Protocol on Outcome From Out-of-Hospital Cardiac Arrest.

Jost D, Degrange H, Verret C, Hersan O, Banville IL, Chapman FW, Lank P, Petit JL, Fuilla C, Migliani R, Carpentier JP; the DEFI 2005 Work Group. Service médical de la Brigade de Sapeurs-Pompiers de Paris, Paris, France.

9. Circulation. 2010 Mar 29. [Epub ahead of print]

Alcohol Intake and Risk of Coronary Heart Disease in Younger, Middle-Aged, and Older Adults.

Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, Heitmann BL, Grønbæk M, O'Reilly E, Bälter K, Goldbourt U, Hallmans G, Knekt P, Liu S, Pereira M, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Rimm EB, Ascherio A. Centre for Alcohol Research, National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.

10. Circulation. 2010 Mar 29.

Nocturnal Rostral Fluid Shift. A Unifying Concept for the Pathogenesis of Obstructive and Central Sleep Apnea in Men With Heart Failure.

Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley  TD.

Toronto Rehabilitation Institute Sleep Research Laboratory.

11. Circulation. 2010 Mar 29. [Epub ahead of print]

Prevalence of Asymptomatic Coronary Artery Disease in Ischemic Stroke Patients. The PRECORIS Study.

Calvet D, Touzé E, Varenne O, Sablayrolles JL, Weber S, Mas JL.

Paris Descartes University, Centre de Psychiatrie et Neurosciences INSERM UMR 894, and Department of Neurology, Centre Hospitalier Sainte-Anne, Paris.

12. Circulation. 2010 Mar 29. [Epub ahead of print]

Elevated Cytosolic Na+ Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes. Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, Böhm M, O'Rourke B, Maack C.

Klinik für Innere Medizin III and Institut für Medizinische Biometrie,
Epidemiologie und Medizinische Informatik, Universitätsklinikum des Saarlandes, Homburg, Germany; and The Johns Hopkins University, Institute of Molecular Cardiobiology, Baltimore, Md.

13. Circulation. 2010 Mar 29. [Epub ahead of print]

Overexpression of Urokinase by Plaque Macrophages Causes Histological Features of Plaque Rupture and Increases Vascular Matrix Metalloproteinase Activity in Aged Apolipoprotein E-Null Mice.
Hu JH, Du L, Chu T, Otsuka G, Dronadula N, Jaffe M, Gill SE, Parks WC, Dichek DA. Department of Medicine, University of Washington School of Medicine, Seattle.

14. Circulation. 2010 Mar 29. [Epub ahead of print]

Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism. The Vienna Prediction Model.
Eichinger S, Heinze G, Jandeck LM, Kyrle PA.
Department of Medicine I, the Karl Landsteiner-Institut für Klinische
Thromboseforschung, and the Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Vienna, Austria.

15. Circulation. 2010 Mar 29.

ACCF/AHA 2010 Position Statement on Composite Measures for Healthcare Performance
Assessment. A Report of the American College of Cardiology Foundation/American
Heart Association Task Force on Performance Measures (Writing Committee to
Develop a Position Statement on Composite Measures).

Peterson ED, Delong ER, Masoudi FA, O'Brien SM, Peterson PN, Rumsfeld JS, Shahian
DM, Shaw RE.

1: Priou P, Hamel JF, Person C, Meslier N, Racineux JL, Urban T, Gagnadoux F. LONG-TERM OUTCOME OF NONINVASIVE POSITIVE PRESSURE VENTILATION FOR OBESITY HYPOVENTILATION SYNDROME. Chest. 2010 Mar 26.

2: Heffner JE, Mularski RA, Calverley PM. COPD Performance Measures: Missing Opportunities for Improving Care. Chest. 2010 Mar 26.

3: Aloia MS, Knoepke CE, Lee-Chiong T. The New Local Coverage Determination Criteria for Adherence to Positive Airway Pressure Treatment: Testing the Limits? Chest. 2010 Mar 26.

4: Vazquez R, Gheorghe C, Ramos F, Dadu R, Amoateng-Adjepong Y, Manthous CA."GURGLING" BREATH SOUNDS MAY PREDICT HOSPITAL-ACQUIRED PNEUMONIA. Chest. 2010 Mar 26.

5: Baughman RP, Engel PJ, Taylor L, Lower EE. Survival in sarcoidosis associated  pulmonary hypertension: the importance of hemodynamic evaluation. Chest. 2010 Mar 26.

6: van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary Function in Diabetes: A Meta-analysis. Chest. 2010 Mar 26.

7: Hwangbo B, Lee GK, Lee HS, Lim KY, Lee SH, Kim HY, Lee HS, Kim MS, Lee JM, Nam BH, Zo JI. Transbronchial and Transesophageal Fine Needle Aspiration Using an Ultrasound Bronchoscope in Mediastinal Staging of Potentially Operable Lung Cancer. Chest. 2010 Mar 26.

8: Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are Airflow Obstruction and Radiographic Emphysema Risk Factors for Lung Cancer? A Nested Case-control Study Using Quantitative Emphysema Analysis. Chest. 2010 Mar  26.

9: De Felice C, Guazzi G, Rossi M, Ciccoli L, Signorini C, Leoncini S, Tonni G, Latini G, Valacchi G, Hayek J. UNRECOGNIZED LUNG DISEASE IN CLASSIC RETT SYNDROME: A PHYSIOLOGIC AND HRCT STUDY. Chest. 2010 Mar 26.
10: Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P; for the ProHOSP Study Group. Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial. Chest. 2010 Mar 18.

11: Slatore CG, Cecere LM, Reinke LF, Ganzini L, Udris EM, Moss BR, Bryson CL, Curtis JR, Au DH. Patient-Clinician Communication: Associations with Important Health Outcomes among Veterans with COPD. Chest. 2010 Mar 18.

12: Chlan LL, Weinert CR, Skaar DJ, Tracy MF. Patient-controlled Sedation: A Novel Approach to Management of Sedative Therapy with Mechanically Ventilated Patients. Chest. 2010 Mar 18.

13: Negrete-García MC, Velazquez JR, Popoca-Coyotl A, Montes-Vizuet AR,
Juárez-Carvajal E, Teran LM. CXCL12/SDF-1 is associated with leukocyte
recruitment in asthma. Chest. 2010 Mar 18.

14: Lee JY, Yi CA, Kim TS, Kim H, Kim J, Han J, Kwon OJ, Lee KS, Chung MJ. CT features as predictors of patient outcome after bronchial intervention in endobronchial tuberculosis. Chest. 2010 Mar 18.

15: Romero CM, Marambio A, Larrondo J, Walker K, Lira MT, Tobar E, Cornejo R, Ruiz M. Swallowing dysfunction in non-neurological critically ill patients who require percutaneous dilatational tracheostomy. Chest. 2010 Mar 18.

16: Ford PA, Durham AL, Russell RE, Gordon F, Adcock IM, Barnes PJ. Treatment effects of low dose theophylline combined with an inhaled corticosteroid in COPD. Chest. 2010 Mar 18.

17: Bleier BS, Cohen NM, Bloom JD, Palmer JN, Cohen NA. Laser Tissue Welding in Lung and Tracheobronchial Repair: An Animal Model. Chest. 2010 Mar 18.

18: Kim J, Lee S, Bhattacharjee R, Khalyfa A, Kheirandish-Gozal L, Gozal D. Leukocyte Telomere Length and Plasma Catestatin and Myeloid Related Protein 8/14  Concentrations in Children with Obstructive Sleep Apnea. Chest. 2010 Mar 18.

19: van de Ven AA, van Montfrans JM, Terheggen-Lagro SW, Beek FJ, Hoytema van Konijnenburg DP, Kessels OA, de Jong PA. A CT score for the assessment of lung disease in children with common variable immunodeficiency disorders. Chest. 2010 Mar 18.

20: Hwang BF, Lee YL. Air Pollution and Prevalence of Bronchitic Symptoms among Children in Taiwan. Chest. 2010 Mar 18.

1: Tauchi M, Fuchs TA, Kellenberger AJ, Woodward DF, Paus R, Lütjen-Drecoll E.Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost. Br J Dermatol. 2010 Mar 12.

2: Mirastschijski U, Schnabel R, Naumann M, Kähne T. Novel plant
metalloproteinase from Dieffenbachia seguine causes fingertip necrosis. Br J Dermatol. 2010 Mar 12.

3: Kostaki M, Venetz JP, Nseir G, Meylan P, Sahli R, Pascual M, Laffitte E. Giant warts in a kidney transplant patient: regression with sirolimus. Br J Dermatol.2010 Mar 12.

4: Cousen P, Chow K, Colver G. What is the role of ultrasound evaluation of lymph nodes in patients with high-grade squamous cell carcinoma of the head and neck? Br J Dermatol. 2010 Mar 12.

5: Laing ME, Cummins R, O'Grady A, O'Kelly P, Kay EW, Murphy GM. Aberrant DNA Methylation associated with MTHFR C677T Genetic Polymorphism in cutaneous squamous cell carcinoma in renal transplant patients. Br J Dermatol. 2010 Mar 19.

6: Ghoreishi M, Martinka M, Dutz JP. Type 1 interferon signature in the scalp lesions of alopecia areata. Br J Dermatol. 2010 Mar 19.

7: Begnini A, Tessari G, Turco A, Malerba G, Naldi L, Gotti E, Boschiero L, Forni A, Rugiu C, Piaserico S, Fortina AB, Brunello A, Cascone C, Girolomoni G, Gomez-Lira M. PTCH1 gene haplotype association with basal cell carcinoma alter transplantation. Br J Dermatol. 2010 Mar 23.

8: Gonzalez M, Cantatore-Francis J, Orlow S. Androgenetic Alopecia in the Pediatric Population: A retrospective review of 57 patients. Br J Dermatol. 2010  Mar 23.

9: Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, Passeron T. 308 nm excimer lamp versus 308 nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010 Mar 23.

10: Zamiri M, Wylie D, Munro C. PERIPHERAL NERVE BLOCKADE FOR BIOPSY OF PLANTAR SKIN. Br J Dermatol. 2010 Mar 24.

11: Kesting MR, Stoeckelhuber M, Hölzle F, Mücke T, Neumann K, Woermann K, Jacobsen F, Steinstraesser L, Wolff KD, Loeffelbein DJ, Rohleder NH. Expression of antimicrobial peptides in cutaneous infections after skin surgery. Br J Dermatol. 2010 Mar 24.

12: Molin S, Ruzicka T. Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol. 2010 Mar 24.

13: Wallengren J, Bartosik J. Botulinum Toxin Type A for neuropathic itch. Br J Dermatol. 2010 Mar 24.

14: Fusi A, Ochsenreither S, Busse A, Rietz A, Keilholz U. Stem cell marker nestin expression in peripheral blood of patients with melanoma. Br J Dermatol. 2010 Mar 24.

15: Soegaard-Madsen L, Johansen C, Iversen L, Kragballe K. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br J Dermatol. 2010 Mar 25.

16: Thyssen JP, Johansen JD, Linneberg A, Menné T, Nielsen NH, Meldgaard M, Szecsi PB, Stender S, Carlsen BC. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol. 2010 Mar 25.

17: Mandal D, Nunns D, Byrne M, McLelland J, Rani R, Cullimore J, Bansal D, Brackenbury F, Kirtschig G, Wier M; British Society for the Study of Vulval Disease (BSSVD) Guideline Group. Guidelines for the management of vulvodynia. Br  J Dermatol. 2010 Mar 16.

18: Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol. 2010 Mar 16.

19: Abeyakirthi S, Mowbray M, Bredenkamp N, van Overloop L, Declercq L, Davis PJ, Matsui MS, Weller RB. Arginase is overactive in psoriatic skin. Br J Dermatol. 2010 Mar 17.

20: Vähävihu K, Ala-Houhala M, Peric M, Karisola P, Kautiainen H, Hasan T, Snellman E, Alenius H, Schauber J, Reunala T. Narrow-band UVB treatment improves  vitamin D balance and alters antimicrobial peptide expression in skin lesions of  psoriasis and atopic dermatitis. Br J Dermatol. 2010 Mar 17.

1: Asherson P, Adamou M, Bolea B, Muller U, Morua SD, Pitts M, Thome J, Young S.
Is ADHD a valid diagnosis in adults? Yes. BMJ. 2010 Mar 26;340:c549. doi:
10.1136/bmj.c549.

2: Moncrieff J, Timimi S. Is ADHD a valid diagnosis in adults? No. BMJ. 2010 Mar
26;340:c547. doi: 10.1136/bmj.c547.

3: Wise J. Health expert calls for 25 trusts to be inspected for excess deaths.
BMJ. 2010 Mar 26;340:c1745. doi: 10.1136/bmj.c1745.

4: Mooney H. Healthcare services at Yarl's Wood detention centre are still
inadequate, report says. BMJ. 2010 Mar 26;340:c1734. doi: 10.1136/bmj.c1734.

5: Sheldon T. Religious leaders call for an end to discrimination against people
living with AIDS. BMJ. 2010 Mar 26;340:c1726. doi: 10.1136/bmj.c1726. PubMed

6: Kmietowicz Z. NHS cuts will make up a third of {pound}11bn savings across
public services. BMJ. 2010 Mar 26;340:c1724. doi: 10.1136/bmj.c1724.

7: White C. Obesity treatment is being neglected in favour of prevention, doctor
says. BMJ. 2010 Mar 26;340:c1716. doi: 10.1136/bmj.c1716.

8: Sharma SP. Nepal's premier medical school closes over alleged bribery for exam
papers. BMJ. 2010 Mar 26;340:c1707. doi: 10.1136/bmj.c1707.

9: Yamey G. Do schools hold the key to controlling parasitic disease? BMJ. 2010
Mar 26;340:c1565. doi: 10.1136/bmj.c1565.

10: Reid S, Barbui C. Long term treatment of depression with selective serotonin
reuptake inhibitors and newer antidepressants. BMJ. 2010 Mar 26;340:c1468. doi:10.1136/bmj.c1468.

11: Wise J. Ten more trusts are told to make urgent improvements. BMJ. 2010 Mar26;340:c1757. doi: 10.1136/bmj.c1757.

12: O'Dowd A. NHS could face even tougher targets on efficiency and productivity.BMJ. 2010 Mar 26;340:c1756. doi: 10.1136/bmj.c1756.

13: Goodyear M. Everybody's responsibility. BMJ. 2010 Mar 26;340:c1744. doi:10.1136/bmj.c1744.

14: Dickson I. GPs left in a quandary. BMJ. 2010 Mar 26;340:c1740. doi:
10.1136/bmj.c1740.

15: Vallance-Owen AJ. Benefits of cooperation. BMJ. 2010 Mar 26;340:c1737. doi:10.1136/bmj.c1737.

16: Van Duppen D. Solidarity to achieve equality. BMJ. 2010 Mar 26;340:c1733.doi: 10.1136/bmj.c1733.

17: Burrill PD. Evidence is lacking. BMJ. 2010 Mar 26;340:c1613. doi:
10.1136/bmj.c1613.

18: Bamji AN. Does care at home mean no care? BMJ. 2010 Mar 26;340:c1334. doi:10.1136/bmj.c1334.

19: Mehanna H, Jones TM, Gregoire V, Ang KK. Oropharyngeal carcinoma related tohuman papillomavirus. BMJ. 2010 Mar 25;340:c1439. doi: 10.1136/bmj.c1439.

20: Banning AP, Cuculi F, Lim CC. Takotsubo cardiomyopathy. BMJ. 2010 Mar25;340:c1272. doi: 10.1136/bmj.c1272.

1: Hain M, Bawnik Y, Warman M, Halperin D, Leiba H. Neonatal dacryocele with endonasal cyst: revisiting the management. Am J Otolaryngol. 2010 Jan 8.

2: Bai W, Shao C, Sun W, Ha PK, Califano JA, Cao Z. Conservative management of transnasal intracranial injury. Am J Otolaryngol. 2010 Jan 6.

3: Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media  and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2009  Dec 23.

4: Kong SK, Goh EK, Lee IW, Chon KM. The effect of radiosurgery on cochlear implant function. Am J Otolaryngol. 2009 Dec 23. [Epub ahead of print]

5: Irani S. Metastasis to head and neck area: a 16-year retrospective study. Am J Otolaryngol. 2009 Dec 21.

6: Terao K, Cureoglu S, Schachern PA, Paparella MM, Morita N, Nomiya S, Inagaki T, Mori K, Murata K. Pathologic correlations of otologic symptoms in acute lymphocytic leukemia. Am J Otolaryngol. 2009 Dec 18.

7: Kim MG, Jung YG, Eun YG. Effect of steroid, carbogen inhalation, and
lipoprostaglandin E(1) combination therapy for sudden sensorineural hearing loss. Am J Otolaryngol. 2009 Dec 18.

8: Soon VT. Pediatric subperiosteal orbital abscess secondary to acute sinusitis: a 5-year review. Am J Otolaryngol. 2009 Dec 21.

9: Wang JJ, Wang Y, Chang PH, Lee TJ, Wang DH. Nontraumatic and postirradiated intracavernous carotid hemorrhage: an unusual case of epistaxis and review of the literature. Am J Otolaryngol. 2009 Dec 18.

10: Claudia G. Re: Analysis of 60 patients after tympanotomy and sealing of the round window membrane after acute unilateral sensorineural hearing loss. Am J Otolaryngol. 2009 Dec 18.

11: Watanabe K, Nakaya M, Miyano K, Abe K. Laryngotracheal separation procedure for elderly patients. Am J Otolaryngol. 2009 Dec 18.

12: Bourolias C, Gkotsis A. Sphenoid sinus barotrauma after free diving. Am J Otolaryngol. 2009 Dec 18.

13: Wu J, Liu B, Fan J, Zhu Q, Wu J. Study of protective effect on rat cochlear spiral ganglion after blast exposure by adenovirus-mediated human beta-nerve growth factor gene. Am J Otolaryngol. 2009 Dec 18.

14: Ohmann EL, Branstetter BF 4th, Johnson JT. The utility of fine needle aspiration to identify unusual pathology in a parapharyngeal mass. Am J Otolaryngol. 2009 Dec 18.

15: D'Ambrosio N, Kellman RM, Karimi S. Osteochondroma of the coronoid process (Jacob's disease): an unusual cause of restricted jaw motion. Am J Otolaryngol. 2009 Dec 18.

16: Rivera-Serrano CM, Schaitkin BM. Bilateral giant submandibular sialoliths and the role for salivary endoscopy. Am J Otolaryngol. 2009 Dec 18.

17: Lee DH. Re: Analysis of 60 patients after tympanotomy and sealing of the round window membrane after acute unilateral sensorineural hearing loss. Am J Otolaryngol. 2009 Dec 18.

18: Henkin RI, Potolicchio SJ Jr, Levy LM. Improvement in smell and taste dysfunction after repetitive transcranial magnetic stimulation. Am J Otolaryngol. 2009 Dec 18.

19: Oretti G, Giordano D, Di Lella F, Gradoni P, Zendri E, Ferri T. Unilesional pemphigus vulgaris of the scalp after cochlear implantation. Am J Otolaryngol. 2009 Oct 30.

20: Hashemi B, Bayat A, Kazemei T, Azarpira N. Comparison between topical honey and mafenide acetate in treatment of auricular burn. Am J Otolaryngol. 2009 Nov 23.

1: Macones GA, Cahill AG, Stamilio DM, Odibo A. Abdominal sacrocolpopexy and urinary incontinence: Elser et al. Am J Obstet Gynecol. 2010 Apr;202(4):403-404. 

2: Pozharny Y, Lambertini L, Ma Y, Ferrara L, Litton CG, Diplas A, Jacobs AR, J, Stone JL, Wetmur J, Lee MJ. Genomic loss of imprinting in Chen first-trimester human placenta. Am J Obstet Gynecol. 2010 Apr;202(4):391.e1-391.e8.

3: Lee J, Park JS, Norwitz ER, Kim BJ, Park CW, Jun JK, Syn HC. Identification and characterization of proteins in amniotic fluid that are differentially expressed before and after antenatal corticosteroid administration. Am J Obstet Gynecol. 2010 Apr;202(4):388.e1-388.e10.

4: Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol. 2010 Apr;202(4):393.e1-393.e7.

5: Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human  placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010 Apr;202(4):383.e1-383.e7.

6: Biron-Shental T, Sukenik-Halevy R, Sharon Y, Goldberg-Bittman L, Kidron D, Fejgin MD, Amiel A. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2010 Apr;202(4):381.e1-381.e7.

7: Goetzl L, Manevich Y, Roedner C, Praktish A, Hebbar L, Townsend DM. Maternal and fetal oxidative stress and intrapartum term fever. Am J Obstet Gynecol. 2010  Apr;202(4):363.e1-363.e5.

8: Gómez LM, Sammel MD, Appleby DH, Elovitz MA, Baldwin DA, Jeffcoat MK, Macones  GA, Parry S. Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol. 2010 Apr;202(4):386.e1-386.e6.

9: Cahill AG, Odibo AO, Allsworth JE, Macones GA. Frequent epidural dosing as a marker for impending uterine rupture in patients who attempt vaginal birth after  cesarean delivery. Am J Obstet Gynecol. 2010 Apr;202(4):355.e1-355.e5.

10: Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol. 2010 Apr;202(4):353.e1-6.

11: Dietz HP. Pelvic floor ultrasound: a review. Am J Obstet Gynecol. 2010Apr;202(4):321-334.

12: Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, Sheffield JS, Perez-Delboy A, Wing DA, Guzman ER; Vaginal Ultrasound Trial Consortium. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet  Gynecol. 2010 Apr;202(4):351.e1-351.e6.

13: Kersting A, Kroker K, Steinhard J. Psychiatric morbidity after termination of pregnancy for fetal anomaly. Am J Obstet Gynecol. 2010 Apr;202(4):e6.

14: Zapardiel I, Peiretti M, Godoy-Tundidor S. Concurrent puerperal hysterectomy  with Ascaris lumbricoides infestation: coincidence or consequence? Am J Obstet Gynecol. 2010 Apr;202(4):e4-e5.

15: Macones GA, Cahill AG, Stamilio DM, Odibo A. Discussion: 'Abdominal
sacrocolpopexy and urinary incontinence' by Elser et al. Am J Obstet Gynecol. 2010 Apr;202(4):e1-e3.

16: Danzer E, Gerdes M, Bebbington MW, Zarnow DM, Adzick NS, Johnson MP. Preschool neurodevelopmental outcome of children following fetal myelomeningocele closure. Am J Obstet Gynecol. 2010 Mar 26.

17: Meler E, Figueras F, Bennasar M, Gomez O, Crispi F, Gratacos E. The
prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia. Am J Obstet Gynecol. 2010 Mar 26.

18: Messalli EM, Annona S. Really, really permanent Well into menopause, the patient experienced a complication from a cesarean delivery. Am J Obstet Gynecol. 2010 Mar 26.

19: Flores-Le Roux JA, Chillaron JJ, Goday A, Puig De Dou J, Paya A,
Lopez-Vilchez MA, Cano JF. Peripartum metabolic control in gestational diabetes.  Am J Obstet Gynecol. 2010 Mar 13.